Familial Aggregation of the Metabolic Syndrome: Tehran Lipid and Glucose Study

被引:23
作者
Azizi, Fereidoun [1 ]
Farahani, Zeinab Kishani [1 ]
Ghanbarian, Arash [1 ]
Sheikholeslami, Farhad [1 ]
Mirmiran, Parvin [1 ]
Momenan, Amir Abbas [1 ]
Asl, Saleh Zahedi [1 ]
Hadaegh, Farzad [1 ]
Eskandari, Fateme [1 ]
机构
[1] Shahid Beheshti Univ MC, Endocrine Res Ctr, Tehran, Iran
关键词
Metabolic syndrome; Familial aggregation; Adolescents; Iranian; INSULIN-RESISTANCE SYNDROME; GENETIC-ANALYSIS; OBESITY; PREVALENCE; HERITABILITY; LIPOPROTEIN; FEATURES; HYPERTENSION; PREVENTION; PLASMA;
D O I
10.1159/000217816
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims: Familial aggregation of the metabolic syndrome has been reported in some nations. The aim of this study was to evaluate familial aggregation of the metabolic syndrome in Tehranian families. Methods: In a cross-sectional study, anthropometry, blood pressure and biochemical data were collected for 4,558 individuals in the Tehran Lipid and Glucose Study. Variables of the metabolic syndrome in offspring were correlated with those of their parents. Results: There were 1,274 fathers, 1,576 mothers, 802 sons and 906 daughters. Prevalence of metabolic syndrome was 24.4% for fathers, 39.7% for mothers, 9.0% for sons and 7.6% for daughters. Triglycerides and HDL-C of children whose fathers had metabolic syndrome, and BMI, triglycerides and HDL-C of those whose mothers had it were significantly different from those adolescents whose parents were free of metabolic syndrome. Compared with children whose parents did not have metabolic syndrome, the odds ratio (confidence interval) for children with both parents having metabolic syndrome was 4.53 (2.42-8.8) for metabolic syndrome, 2.22 (1.17-4.19) for abdominal obesity, 1.90 (1.15-3.13) for high blood pressure, 2.66 (1.77-4.00) for low HDL-C and 3.16 (2.10-4.75) for high triglyceride levels. Conclusion: This survey provides evidence suggesting that there is a familial aggregation of the metabolic syndrome among Iranian families. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:189 / 196
页数:8
相关论文
共 30 条
[1]
[Anonymous], 1997, WHO TECHN REP SER
[2]
AZADBAKHT L, 2005, INT J VITAM NUTR RES, V75, P347
[3]
AZADBAKHT L, 2004, IJEM, V5, P379
[4]
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study [J].
Azizi, F ;
Salehi, P ;
Etemadi, A ;
Zahedi-Asl, S .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 61 (01) :29-37
[5]
Azizi F., 2000, CVD Prev, V3, P242
[6]
Beck-Nielsen H, 1999, DRUGS, V58, P75
[7]
General characteristics of the insulin resistance syndrome - Prevalence and heritability [J].
Beck-Nielsen, H .
DRUGS, 1999, 58 (Suppl 1) :7-10
[8]
CARMELLI D, 1994, AM J HUM GENET, V55, P566
[9]
Prevalence and trends of a metabolic syndrome phenotype adolescents, 1999-2000 [J].
Duncan, GE ;
Li, SM ;
Zhou, XH .
DIABETES CARE, 2004, 27 (10) :2438-2443
[10]
High prevalence of the metabolic syndrome in Iranian adolescents [J].
Esmaillzadeh, Ahmad ;
Mirmiran, Parvin ;
Azadbakht, Leila ;
Etemadi, Arash ;
Azizi, Fereidoun .
OBESITY, 2006, 14 (03) :377-382